相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neuropeptide Y Y1 Receptor Hippocampal Overexpression Via Viral Vectors Is Associated With Modest Anxiolytic-Like and Proconvulsant Effects in Mice
M. V. Olesen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures
Casper R. Gotzsche et al.
NEUROBIOLOGY OF DISEASE (2012)
Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas
D. Quarta et al.
NEUROPHARMACOLOGY (2011)
Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice
Lene S. Schmidt et al.
PSYCHOPHARMACOLOGY (2011)
A Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors Plays a Critical Role in Modulating Dopamine-Dependent Behaviors
Jongrye Jeon et al.
JOURNAL OF NEUROSCIENCE (2010)
Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M-5 muscarinic receptor knockout mice
Lene S. Schmidt et al.
PSYCHOPHARMACOLOGY (2010)
Heterogeneity and diversity of striatal GABAergic interneurons
James M. Tepper et al.
FRONTIERS IN NEUROANATOMY (2010)
The Novel Neuropeptide Y Y5 Receptor Antagonist Lu AA33810 [N-[[trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] Exerts Anxiolytic- and Antidepressant-Like Effects in Rat Models of Stress Sensitivity
Mary W. Walker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Neuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamine
Gunnar Sorensen et al.
NEUROREPORT (2009)
Neuropeptide Y augments cocaine self-administration and cocaine-induced hyperlocomotion in rats
Tia Maric et al.
PEPTIDES (2009)
Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice
Gunnar Sorensen et al.
PSYCHOPHARMACOLOGY (2008)
Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum:: Mediation byY2 receptors
Adepero Shola Adewale et al.
NEUROPHARMACOLOGY (2007)
A neuropeptide YY5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice
A Ishihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Distribution of NPYY5-like immunoreactivity in the rat brain
S. Michelle Morin et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors
DPD Woldbye et al.
NEUROBIOLOGY OF DISEASE (2005)
The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats
JP Schroeder et al.
ALCOHOL (2005)
Application of triple-probe microdialysis for fast pharmacokinetic/pharmacodynamic evaluation of dopamimetic activity of drug candidates in the rat brain
P Weikop et al.
JOURNAL OF NEUROSCIENCE METHODS (2004)
Dopamine and drug addiction: the nucleus accumbens shell connection
G Di Chiara et al.
NEUROPHARMACOLOGY (2004)
Role for M5 muscarinic acetylcholine receptors in cocaine addiction
A Fink-Jensen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Comparative distribution of neuropeptide YY1 and Y5 receptors in the rat brain by using immunohistochemistry
ML Wolak et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Neuropeptide-Y Y5 receptors modulate the onset and maintenance of operant ethanol self-administration
JP Schroeder et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2003)
Distinct roles of the Y1 and Y2 receptors on neuropeptide Y-induced sensitization to sedation
P Naveilhan et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Expression of a novel neuropeptide Y receptor subtype involved in food intake:: An in situ hybridization study of Y5 mRNA distribution in rat brain
MM Durkin et al.
EXPERIMENTAL NEUROLOGY (2000)
Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice
T Rasmussen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)